Rooted in data, driven by humanity.
What we do
The Vaccine Confidence Project™ (VCP) was established in 2010 by Professor Heidi Larson at the London School of Hygiene and Tropical Medicine to better understand growing vaccine scepticism around the world.
The VCP was the first research group to map and monitor public confidence in vaccination at a global scale and remains the only research group fully dedicated to understanding the roots, trends over time, and impacts of vaccine confidence.
By listening to early signs of public distrust and providing risk analysis and guidance, we aim to engage early to prevent potential programme disruptions and support vaccination rates.
About the VCP
Latest research projects
The VCP conducts global research, investigating the roots, trends over time and impacts of vaccine confidence at regional, national and sub-national levels.
We partnered with Wits Vida, the Vaccine Confidence Fund, and PHRU to study how much, if at all, social media and community influencers can influence and increase uptake of influenza vaccines.
Strengthen national training curricula and integrate targeted, culturally grounded interpersonal communication practices into training curricula for health workers in ECARO countries.
Mixed method study to examine adult and HCP confidence in vaccination in Eastern Europe (Balkans, Caucasus, Central Asia).
Mixed method study to explore risk perceptions and emotional determinants of health around COVID-19 and influenza vaccination in Europe.
Vaccine Confidence Index
Our team has conducted research in over 150 countries from 2015 to the present, helping to identify critical global trends in vaccine confidence with implications for global health.
Explore the map
In the oil towns of west Texas, a measles outbreak is spreading. Gaines County, where the flare-up began, had the state’s third-highest share of children exempt from measles and other vaccines for religious or philosophical reasons last year
The way to discuss a vaccine, says Prof. Heidi Larson, founding director of the Vaccine Confidence Project, is to ask your patient how they feel about it and go from there, addressing patient concerns and developing a risk-benefit analysis to discuss.
This series of studies highlights the importance of adopting constructive approaches to restoring public health confidence in vaccination, particularly mRNA vaccines.
Professor Heidi Larson spoke to The i Paper about the role of the Covid pandemic in driving vaccine confidence declines among 18 to 24-year-olds: “It was not specifically a reaction to the vaccine. They felt that their education was disrupted, social life restricted and jobs lost or disrupted.”